Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations

Respiratory Medicine

Volumn 105, Issue 6, 2011, Pages 946-949

  Serisier, D J ^a,b   Martin, M L ^a  

^a MATER ADULT HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Bronchiectasis; Erythromycin; Immunomodulation; Macrolides

Indexed keywords

ERYTHROMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BRONCHIECTASIS; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DRUG EFFECT; FEMALE; HUMAN; INFECTIVE EXACERBATION; LOW DRUG DOSE; MALE; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROMYCIN; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 79955472027     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.01.009     Document Type: Article

References (20)

1. A.E. O'Donnell, A.F. Barker, J.S. Ilowite, and Rb Fick Treatment of idiopathic bronchiectasis with aerosolised recombinant human DNase 1 Chest 113 1998 1329 1334 (Pubitemid 28223825)
2. A.F. Barker, L. Couch, S.B. Fiel, M.H. Gotfried, J. Ilowite, and K.C. Meyer Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis Am J Respir Crit Care Med 162 2000 481 485 (Pubitemid 30647187)
3. D. Bilton, N. Henig, B. Morrissey, and M. Gotfried Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis Chest 130 2006 1503 1510 (Pubitemid 44786746)
4. G.A. Anwar, S.C. Bourke, G. Afolabi, P. Middleton, C. Ward, and P.M. Rutherford Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis Respir Med 102 2008 1494 1496
5. G. Davies, and R. Wilson Prophylactic antibiotic treatment of bronchiectasis with azithromycin Thorax 59 2004 540 541 (Pubitemid 38797534)
6. A.A. Cymbala, L.C. Edwards, M.A. Bauer, P.J. Jederlinic, J.J. May, and J.M. Victory The disease-modifying effects of twice weekly oral azithromycin in bronchiectasis Treat Respir Med 4 2005 117 122 (Pubitemid 40613959)
7. P.A.J. Crosbie, and M.A. Woodhead Long-term macrolide therapy in chronic inflammatory airway diseases Eur Respir J 33 2009 171 181
8. F. Cokaert, A. Hubloux, and P. Cauchie A phase I determination of azithromycin in plasma during a 6-week period in normal volunteers after a standard dose of 500 mgs once daily for 3 days Clin Drug Invest 16 1998 161 166 (Pubitemid 28430060)
9. S. Malhotra-Kumar, C. Lammens, S. Coenen, K. Van Herck, and H. Goossens Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study Lancet 369 2007 482 490 (Pubitemid 46209315)
10. R. Dias, and M. Canica Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14 J Antimicr Chemother 54 2004 1035 1039 (Pubitemid 40136737)
11. U. Kastner, and J.P. Guggenbichler Influence of macrolide antibiotics on promotion of resistance in oral flora of children Infection 29 2001 251 256 (Pubitemid 32929629)
12. K. Tsang, P. Ho, K. Chan, M. Ip, W. Lam, and C. Ho A pilot study of low-dose erythromycin in bronchiectasis Eur Respir J 13 1999 361 364 (Pubitemid 29086834)
13. D. Bilton Update on non-cystic fibrosis bronchiectasis Curr Opin Pulm Med 14 2008 595 599
14. T.A.R. Seemungal, T.M.A. Wilkinson, J.R. Hurst, W.R. Perera, R.J. Sapsford, and J.A. Wedzicha Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations Am J Respir Crit Care Med 178 2008 1139 1147
15. S. Kudoh, A. Azuma, M. Yamamoto, T. Izumi, and M. Ando Improvement in survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin Am J Respir Crit Care Med 157 1998 1829 1832
16. M. Gorrini, A. Lupi, S. Viglio, F. Pamparana, G. Cetta, and P. Iadarola Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibiotics Am J Respir Cell Mol Biol 25 2001 492 499 (Pubitemid 33037682)
17. H. Takizawa, M. Desaki, T. Ohtoshi, S. Kawasaki, T. Kohyama, and M. Sato Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells Am J Respir Crit Care Med 156 1995 266 271 (Pubitemid 27293200)
18. O.A. Khair, J.L. Devalia, M.M. Abdelaziz, R.J. Sapsford, and R.J. Davies Effect of erythromycin on Haemophilus influenzae endotoxin- induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells Eur Respir J 8 1995 1451 1457
19. D. Inoue, H. Kubo, T. Sasaki, H. Yasuda, M. Numasaki, and H. Sasaki Erythromycin attenuates MUC5AC synthesis and secretion in cultured human tracheal cells infected with RV14 Respirology 13 2008 215 220 (Pubitemid 351388775)
20. T. Shimizu, S. Shimizu, R. Hattori, E.C. Gabazza, and Y. Majima In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells Am J Respir Crit Care Med 168 2003 581 587 (Pubitemid 37088602)